Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
sanofi-aventis, Building H831, Room C 0441, Frankfurt, Germany. reinhard.becker@sanofi-aventis.com
Reinhard H A
RH
Becker
Annke D
AD
Frick
Leszek
L
Nosek
Lutz
L
Heinemann
Klaus
K
Rave
D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015992:Body Mass Index; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D015309:Glucose Clamp Technique; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; C479079:insulin glulisine